Linscomb & Williams, Inc.
- SEC CIK
- 0001313294
- Latest filing
- Jul 31, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Linscomb & Williams, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −2,443−100.0% | Sold out | Holders |
| Q4 2024 | 2,443 | $210.1K | <0.1% | −650−21.0% | Reduced | Holders |
| Q3 2024 | 3,093 | $368.3K | <0.1% | −3,479−52.9% | Reduced | Holders |
| Q2 2024 | 6,572 | $938.0K | <0.1% | +83+1.3% | Added | Holders |
| Q1 2024 | 6,489 | $833.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 6,489 | $671.3K | <0.1% | +689+11.9% | Added | Holders |
| Q3 2023 | 5,800 | $527.5K | <0.1% | 00.0% | UnchangedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 2,900 | $469.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,900 | $461.5K | <0.1% | −10.0% | Reduced | Holders |
| Q4 2022 | 2,901 | $392.6K | <0.1% | +10.0% | Added | Holders |
| Q3 2022 | 2,900 | $289.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 2,900 | $323.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,900 | $322.0K | <0.1% | −10−0.3% | Reduced | Holders |
| Q4 2021 | 2,910 | $326.0K | <0.1% | −195−6.3% | Reduced | Holders |
| Q3 2021 | 3,105 | $298.0K | <0.1% | +5+0.2% | Added | Holders |
| Q2 2021 | 3,100 | $260.0K | <0.1% | −385−11.0% | Reduced | Holders |
| Q1 2021 | 3,485 | $235.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.